Effects of duloxetine, an antidepressant drug candidate on concentrations of monoamines and their metabolites in rats and mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 269, Issue 1, 1994, Pages 132-136

  Fuller, R W ^a   Hemrick Luecke, S K ^a   Snoddy, H D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; BRAIN MONOAMINE; CHLORAMPHETAMINE; DULOXETINE; OXIDOPAMINE;

5 HYDROXYINDOLEACETIC ACID BRAIN LEVEL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; FRONTAL CORTEX; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; SEROTONIN RELEASE; SEROTONIN UPTAKE;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMAL; ANTIDEPRESSIVE AGENTS; BIOGENIC MONOAMINES; BRAIN; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROXYINDOLEACETIC ACID; MALE; MICE; MICE, INBRED ICR; MONOAMINE OXIDASE INHIBITORS; NEUROTRANSMITTER UPTAKE INHIBITORS; NOREPINEPHRINE; OXIDOPAMINE; P-CHLOROAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; THIOPHENES;

EID: 0028326399     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)